CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update


CNBX Pharmaceuticals Inc. (OTCMKTS:CNBXGet Rating) was the recipient of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 300 shares, an increase of 200.0% from the January 15th total of 100 shares. Based on an average daily volume of 84,500 shares, the days-to-cover ratio is presently 0.0 days.

CNBX Pharmaceuticals Trading Down 11.4 %

CNBX Pharmaceuticals stock opened at $0.12 on Monday. The stock has a fifty day moving average price of $1.77 and a two-hundred day moving average price of $2.96. CNBX Pharmaceuticals has a 52-week low of $0.11 and a 52-week high of $12.00.

About CNBX Pharmaceuticals

(Get Rating)

CNBX Pharmaceuticals, Inc is a biopharmaceutical company. It engages in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. The company was founded by Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.

See Also



Receive News & Ratings for CNBX Pharmaceuticals Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CNBX Pharmaceuticals and related companies with MarketBeat.com’s FREE daily email newsletter.

Read more here: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *